SweetBio
Memphis, US · Founded 2015 · Delaware corporation · 4 known investors
Find your way into SweetBio
328 people in our graph share verified history with the SweetBio team — schools, employers, funds. One of them is your warm intro.
Mike Zakunlockedknows Kayla Rodriguez · together at Cornell (overlapped)
×4knows the team · via Cornell
×2knows the team · via Target
×2knows the team · via Virginia Commonwealth University
×3knows the team · via Hult International Business School
SweetBio develops wound care dressings that combine collagen and Mānuka honey to help close chronic and acute non-healing wounds. Its products are used in clinical wound care settings and are reimbursed by Medicare, commercial plans, and available in VA and Department of Defense facilities.
Founders & leadership
SweetBio was founded in 2015 by Isaac Rodriguez and Kayla Rodriguez.
IR
Isaac RodriguezinCo-Founder & Chief Science OfficerIsaac Rodriguez holds a doctorate and co-founded SweetBio, where he leads scientific strategy for the company's collagen and Mānuka honey wound care platform. He co-invented the honey-based biomaterial technology underlying the product line and has published research in regenerative medicine and biomaterials.
KR
Kayla RodriguezinCo Founder & CEOCEO and co-founder of SweetBio, Kayla Rodriguez previously spent 10 years in medical device venture development and 6 years in operations strategy and mass market experience at Target Corp.
MW
Marsalas WhitakerinExecutive
KG
Kevin GraffNamed on SEC filing
Investors · 4
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 4 of 8 rounds · 2015–2024
▶$1.5MofferedApr 2024 · Other Health CareRule 506(b)
▶$1.5MofferedApr 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kayla GraffExecutive Officer, Director
- Isaac RodriguezExecutive Officer, Director
- Kevin GraffExecutive Officer, Director
- Offering amount
- $1.5M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MofferedNov 2023 · Other Health CareRule 506(b)
▶$6MofferedNov 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Isaac RodriguezExecutive Officer, Director
- Jan BoutenDirector
- Kevin GraffExecutive Officer
- Kayla GraffExecutive Officer, Director
- Offering amount
- $6M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MofferedJan 2023 · Other Health CareRule 506(b)
▶$1MofferedJan 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jan BoutenDirector
- Isaac RodriguezExecutive Officer, Director
- Kayla GraffExecutive Officer, Director
- Kevin GraffExecutive Officer
- Offering amount
- $1M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KofferedApr 2022 · Other Health CareRule 506(b)
▶$500KofferedApr 2022 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Isaac RodriguezExecutive Officer, Director
- Kevin GraffExecutive Officer
- Jan BoutenDirector
- Kayla GraffExecutive Officer, Director
- Offering amount
- $500K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$590KraisedOct 2020 · 13 investors · Other Health CareRule 506(b)
▶$590KraisedOct 2020 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jan BoutenDirector
- Kayla GraffExecutive Officer, Director
- Isaac RodriguezExecutive Officer, Director
- Kevin GraffExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $590K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$803.6KraisedSep 2019 · 11 investors · Other Health CareRule 506(b)
▶$803.6KraisedSep 2019 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kayla GraffExecutive Officer, Director
- Jan BoutenDirector
- Kevin GraffExecutive Officer
- Isaac RodriguezExecutive Officer, Director
- Offering amount
- $810K
- Amount sold
- $803.6K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.1MraisedNov 2018 · 19 investors · Other Health CareRule 506(b)
▶$3.1MraisedNov 2018 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin GraffExecutive Officer
- Kayla GraffExecutive Officer, Director
- Jan BoutenDirector
- Isaac RodriguezExecutive Officer, Director
- Offering amount
- $3.3M
- Amount sold
- $3.1M
- Minimum investment
- $25K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$100KraisedMay 2015 · 3 investors · Other Health CareRule 506(b)
▶$100KraisedMay 2015 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marsalas WhitakerExecutive Officer, Director
- Kevin GraffExecutive Officer
- Isaac RodriguezExecutive Officer, Director
- Kayla RodriguezExecutive Officer, Director
- Offering amount
- $100K
- Amount sold
- $100K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
BodyBio5 shared keywordsBodyBio is a third-generation family business that develops and manufactures science-backed dietary supplements and vitamins, including phosphatidylcholine (PC), butyrate, and detox products, aimed at cellular health and wellness. Products are made at the company's in-house facility with third-party testing.
Bridgebio3 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Sword Bio3 shared keywordsSword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.
Companies competing with SweetBio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does SweetBio do?
- SweetBio develops wound care dressings that combine collagen and Mānuka honey to help close chronic and acute non-healing wounds. Its products are used in clinical wound care settings and are reimbursed by Medicare, commercial plans, and available in VA and Department of Defense facilities.
- Who founded SweetBio?
- SweetBio was founded by Isaac Rodriguez, Kayla Rodriguez in 2015.
- Who are SweetBio's investors?
- SweetBio's investors include Innova Memphis, Inc., Launch Tennessee, VamosVentures, Innova.
- How much funding has SweetBio raised?
- SweetBio has disclosed $4.6M raised across 4 of its 8 known rounds.
- Where is SweetBio headquartered?
- SweetBio is headquartered in Memphis, US.